ClinicalTrials.gg
CompletedNCT05328947Updated Jul 16, 2024

Normative Biomechanical Measures of Reaching in Able-Bodied Adults

An interventional study of Modified Functional Reach and Functional Reach in Individuals With Functional Limitations Which May Impact Their Forward Reach, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 20 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-16.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
20 Years to 59 Years
Sex
All
01

Study summary

A study to obtain normative values and repeatability measures during functional reaching tasks in able-bodied individuals with no functional limitations.

Read the detailed description

The study has three main aims: 1) Define the data collection methods, and calculate the repeatability, of joint angles, muscle activation magnitudes, seating pressure, foot pressure, and reach distance during seated and standing reaching activities. 2) Collect normative values of joint angles, muscle activation magnitudes, seating pressure, foot pressure, and reach distance during seated and standing functional reaching tasks in 40 participants with no functional limitations. Descriptive statistics will include calculating the mean, median, standard deviation, and range of the outcome variable values. 3) Compare joint angles, muscle activation magnitudes, seating pressure, foot pressure, and reach distance collected during a seated reaching task to those collected during a standing reaching task.

The data collected may be used in the future as baseline reference and repeatability values of outcome measures against which to compare values from individuals with functional limitations to quantify their functional ability.

02

Conditions studied

  • Individuals With Functional Limitations Which May Impact Their Forward Reach
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,264 studies on the registry; 670 are open to participants now.

Of its 450 completed or terminated interventional studies of FDA-regulated products, 318 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 20-59 years of age at time of enrollment

Exclusion criteria

Exclusion Criteria:

  • Failure to give consent or follow simple commands
  • Score of 7 or above on the QuickDASH Outcome Measure
  • Score of 5 or above on the Oswestry Low Back Disability Questionnaire
  • Score of 76 or below on the Lower Extremity Functional Scale
  • Diagnosis of a neuromuscular disorder (e.g., muscular dystrophy, multiple sclerosis, fibromyalgia)
  • Diagnosis of an inner ear balance disorder (e.g., benign paroxysmal positional vertigo)
  • Insufficient active range of motion of bilateral shoulders or hips that results in inability to perform forward or lateral reaching tasks
  • Any illness or condition which, based on the research team's assessment, will compromise the patient's ability to comply with the protocol, patient safety, or the validity of the data collected during this study
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Normal Controls

    Other: Modified Functional Reach and Functional Reach

Interventions

  • OtherModified Functional Reach and Functional Reach

    Establishment of Modified Functional Reach Test (mFRT) and Function Reach Test (FRT) values for individuals with no functional impairments.

06

What researchers measure

Primary outcomes

  1. Joint angles

    Change in measurements of joint angles at the shoulders, hips, knees, and ankles, measured in degrees.

    Time frame: One data collection session, lasting approximately 4 hours

  2. Electromyography

    Muscle activity over time and peak muscle activity, measured in volts. Muscles measured: erector spinae, rectus abdominis, gluteus maximus, gluteus medius, medial hamstring, vastus lateralis, gastrocnemius, and tibialis anterior.

    Time frame: One data collection session, lasting approximately 4 hours

  3. Center of pressure excursion

    Path of movement of the center of pressure applied by the buttocks to the seating surface and applied by the feet to the floor.

    Time frame: One data collection session, lasting approximately 4 hours

  4. Seated and foot pressures

    Plot of pressure magnitude over the surface of the buttocks and the bottom of the feet.

    Time frame: One data collection session, lasting approximately 4 hours

  5. Reach distance

    Measurement of the furthest distance reached, measured in centimeters.

    Time frame: One data collection session, lasting approximately 4 hours

07

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55905, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2022 to primary completion in Jun 2023, 11 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2022
First posted
Apr 14, 2022
StartActual
Jul 14, 2022
Primary completionActual
Jun 29, 2023
CompletionActual
Jun 29, 2023
Last update
Jul 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05328947
Lead sponsor
Mayo Clinic
Responsible party
Kristin Zhao, PhD (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Apr 14, 2022
Start date
Jul 14, 2022
Primary completion
Jun 29, 2023
Completion
Jun 29, 2023
Last update
Jul 16, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion